GSK (GSK) RNS Announcements

Add to Alert list
Date Time Source Announcement
18 Mar 2013 05:04 PM
RNS
Director/PDMR Shareholding
18 Mar 2013 05:02 PM
RNS
Director/PDMR Shareholding
18 Mar 2013 05:00 PM
RNS
Director/PDMR Shareholding
15 Mar 2013 05:23 PM
RNS
Transaction in Own Shares
14 Mar 2013 05:36 PM
RNS
Transaction in Own Shares
13 Mar 2013 05:28 PM
RNS
Transaction in Own Shares
12 Mar 2013 05:36 PM
RNS
Transaction in Own Shares
12 Mar 2013 03:49 PM
RNS
Director/PDMR Shareholding
12 Mar 2013 03:34 PM
RNS
Director/PDMR Shareholding
11 Mar 2013 05:19 PM
RNS
Transaction in Own Shares
11 Mar 2013 10:52 AM
RNS
GSK files its Annual Report 2012 on Form 20-F
08 Mar 2013 05:23 PM
RNS
Transaction in Own Shares
07 Mar 2013 05:43 PM
RNS
Transaction in Own Shares
07 Mar 2013 10:32 AM
RNS
GSK submits albiglutide MAA to the EMA
07 Mar 2013 07:00 AM
RNS
Dolutegravir SAILING study in HIV announced
06 Mar 2013 05:38 PM
RNS
Director/PDMR Shareholding
06 Mar 2013 02:33 PM
RNS
Publication of Annual Report 2012
05 Mar 2013 05:45 PM
RNS
Director/PDMR Shareholding
05 Mar 2013 05:43 PM
RNS
Director/PDMR Shareholding
05 Mar 2013 05:36 PM
RNS
Director/PDMR Shareholding
05 Mar 2013 05:35 PM
RNS
Director/PDMR Shareholding
05 Mar 2013 05:33 PM
RNS
Director/PDMR Shareholding
05 Mar 2013 02:48 PM
RNS
Director/PDMR Shareholding
05 Mar 2013 02:45 PM
RNS
Director/PDMR Shareholding
04 Mar 2013 06:27 PM
RNS
Director/PDMR Shareholding
04 Mar 2013 06:26 PM
RNS
Director/PDMR Shareholding
04 Mar 2013 06:25 PM
RNS
Director/PDMR Shareholding
04 Mar 2013 06:23 PM
RNS
Director/PDMR Shareholding
04 Mar 2013 04:36 PM
RNS
Director/PDMR Shareholding
01 Mar 2013 02:54 PM
RNS
Total Voting Rights
25 Feb 2013 09:56 AM
RNS
Director/PDMR Shareholding
19 Feb 2013 06:04 PM
RNS
Director/PDMR Shareholding
18 Feb 2013 04:58 PM
RNS
Director/PDMR Shareholding
15 Feb 2013 03:09 PM
RNS
Dolutegravir granted FDA priority review
12 Feb 2013 03:15 PM
RNS
Director/PDMR Shareholding
12 Feb 2013 03:11 PM
RNS
Director/PDMR Shareholding
08 Feb 2013 04:38 PM
RNS
Replacement Director/PDMR Shareholding
07 Feb 2013 03:24 PM
RNS
EU submission for BRAF/MEK combination therapy
06 Feb 2013 12:16 PM
RNS
GSK applies IAS19R with effect from 1 January 2013
06 Feb 2013 12:01 PM
RNS
Final Results
05 Feb 2013 02:09 PM
RNS
Director/PDMR Shareholding
05 Feb 2013 07:30 AM
RNS
GSK increases stake in its Indian consumer co.
01 Feb 2013 04:56 PM
RNS
Total Voting Rights
31 Jan 2013 04:21 PM
RNS
Director/PDMR Shareholding
24 Jan 2013 03:37 PM
RNS
Directorate Change
21 Jan 2013 04:53 PM
RNS
Director/PDMR Shareholding
14 Jan 2013 10:00 AM
RNS
GSK submits albiglutide BLA to the US FDA
11 Jan 2013 05:11 PM
RNS
Director/PDMR Shareholding
11 Jan 2013 05:11 PM
RNS
Director/PDMR Shareholding
10 Jan 2013 05:00 PM
RNS
Director/PDMR Shareholding

GSK PLC, known as GSK, is a renowned multinational pharmaceutical and biotechnology company with its global headquarters in London. Traded as GSK on the London Stock Exchange (LSE), it has a rich history that traces back to the establishment of Plough Court Pharmacy in London in 1715. Over the centuries, GSK has grown from a handful of individual founders into a company of over 69,000 people.

The company's journey includes the development of 15 first-in-class or combination vaccines and pioneering medications in respiratory, antibiotics, antivirals, and oncology. GSK has been a leader in medicines that advance the management of asthma and chronic obstructive pulmonary disease (COPD) for 50 years.

In 2000, Glaxo Wellcome and SmithKline Beecham merged to form the modern GSK, becoming a key player on the LSEG. Today, GSK continues to shape the global healthcare landscape, committed to defeating diseases that impact people's health. This evergreen company remains at the forefront of the pharmaceutical industry, embodying its founding principle of improving the quality of human life by enabling people to do more, feel better, and live longer.

UK 100

Latest directors dealings